Skip to main content
padlock icon - secure page this page is secure

Nanomedicines in Bone Cancer—From Diagnostics to Therapies

Buy Article:

$106.34 + tax (Refund Policy)

Bone primary cancer and bone metastases from other tumors pose a threat to millions of people in the world. The developments of nanomedicines have offered unprecedented opportunities to advance the treatment of various diseases, including bone cancer. In this review, we examine recent developments in nanomaterials for bone cancer therapy, in terms of their applications in bone cancer diagnostics and therapies, as well as in model simulation. Taking advantage of their inherent properties and modified with kinds of bioactive ligands, a broad range of nanomedicines based on metallic, lipidic, polymeric, and inorganic nanomaterials have been developed to target bone tumors in vivo and intended for use either as contrast agents for diagnostic imaging or as therapeutic agents in chemotherapy, hyperthermia therapy, photodynamic therapy and photothermal therapy. Moreover, a growing number of biological models with nanomedicines for bone cancer have been developed to study the underlying mechanisms for primary bone tumor and cancer bone metastasis. As cancer nanomedicines are a multidisciplinary area of research including material engineering, pharmacy, tumor biology and clinical medicine, it needs efforts to bridge the knowledge gaps between different areas.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Review Article

Publication date: August 1, 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more